Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade Meeting Abstract
| Authors: | Ricciuti, B.; Gariazzo, E.; Gorria, T.; Thummalapalli, R.; Citarella, F.; Gandhi, M. M.; Elkrief, A.; Pecci, F.; Alessi, J. V. M.; Di Federico, A.; Makarem, M.; Saini, A.; Aldea, M.; Espinar, J. B.; Cortellini, A.; Schoenfeld, A. J.; Nana, F. A.; Mezquita, L.; Metro, G.; Awad, M. M. |
| Abstract Title: | Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402127 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.8633 |
| Notes: | Meeting Abstract: 8633 -- Source: Wos |
